Back to top
more

Medtronic (MDT)

(Real Time Quote from BATS)

$91.77 USD

91.77
2,806,120

-0.97 (-1.05%)

Updated Aug 12, 2025 03:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (145 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Teleflex Hits New 52-Week High: What's Driving the Rally?

by Zacks Equity Research

Teleflex (TFX) is optimistic about maintaining growth momentum on several recent developments.

Zacks Equity Research

Thermo Fisher Rides on New Product Suite, Currency Woes Stay

by Zacks Equity Research

Thermo Fisher Scientific (TMO) recently unveils a product suite comprising the TSQ Altis, Quantis MD mass spectrometers and Vanquish MD HPLC.

Zacks Equity Research

Masimo's Neonatal RD SET Pulse Oximetry Sensors Get FDA Nod

by Zacks Equity Research

Masimo (MASI) will cater to the whole prenatal patient population, with the recent FDA clearance within the SET pulse oximetry business.

Zacks Equity Research

Hologic (HOLX) Divests Cynosure to Focus on Women's Health

by Zacks Equity Research

Hologic (HOLX) expects to witness favorable outcomes from the sell-off of the Cynosure medical aesthetics business, which was its loss-making arm since 2017.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Medtronic, United Technologies, Union Pacific, Vertex Pharmaceuticals and NextEra Energy

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Medtronic, United Technologies, Union Pacific, Vertex Pharmaceuticals and NextEra Energy

Zacks Equity Research

Here's Why You Should Add NuVasive Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about NuVasive (NUVA) on its stellar segmental performance in Q3.

Mark Vickery headshot

Top Research Reports for Medtronic, United Technologies & Union Pacific

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Medtronic (MDT), United Technologies (UTX) and Union Pacific (UNP).

Zacks Equity Research

Medtronic (MDT) Stock Moves 0.68%: What You Should Know

by Zacks Equity Research

In the latest trading session, Medtronic (MDT) closed at $113.35, marking a +0.68% move from the previous day.

Trina Mukherjee headshot

6 MedTech Stocks That are Set to Beat the Market in 2020

by Trina Mukherjee

Banking on the three key trends, we zero in on six MedTech stocks that are likely to deliver stellar performance in 2020.

Zacks Equity Research

Is Medtronic (MDT) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (MDT) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Zacks.com featured highlights include: Synaptics, Target, Medtronic Public, Bristol-Myers Squibb and Integer

by Zacks Equity Research

Zacks.com featured highlights include: Synaptics, Target, Medtronic Public, Bristol-Myers Squibb and Integer

Zacks Equity Research

Medtronic (MDT) Up 1.8% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Here's Why You Should Hold on to Globus Medical Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Globus Medical (GMED) on its stellar segmental performance.

Zacks Equity Research

Medtronic's (MDT) Brain Therapies Device Receives FDA Approval

by Zacks Equity Research

Medtronic (MDT) strengthens its robotics platform with the receipt of regulatory approval and the subsequent upgradation of its enabling technology portfolio.

Zacks Equity Research

5 Stocks Trading Near 52-Week High With More Room to Run

by Zacks Equity Research

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

Zacks Equity Research

Medtronic Acquires Klue to Strengthen Diabetes Management Arm

by Zacks Equity Research

Medtronic (MDT) strengthens its diabetes business through the Klue acquisition and subsequent development of its PCL technology.

Zacks Equity Research

Medtronic (MDT) Inks Deal to Focus on Value-Based Healthcare

by Zacks Equity Research

With shared financial responsibility between ChristianaCare and Medtronic (MDT), this coordinated effort will improve patient outcomes at reduced cost.

Trina Mukherjee headshot

Minimally Invasive Surgery Gains Ground: 3 Stocks in Focus

by Trina Mukherjee

With minimally invasive surgery gaining momentum, these stocks are poised to capitalize on the market prospects.

Zacks Equity Research

Zacks.com featured highlights include: Target, Medtronic Public, Arconic, Science Applications International and Bristol-Myers Squibb

by Zacks Equity Research

Zacks.com featured highlights include: Target, Medtronic Public, Arconic, Science Applications International and Bristol-Myers Squibb

Zacks Equity Research

5 High-Flying Stocks Near 52-Week High With More Room to Run

by Zacks Equity Research

Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Medtronic, Apple, Stryker and Intuitive Surgical

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Medtronic, Apple, Stryker and Intuitive Surgical

Urmimala Biswas headshot

Industry 4.0 to Steer MedTech to Higher Growth: A Sneak Peek

by Urmimala Biswas

Investors need to be bold enough to bet on trend-shifting consumption habits emanating from Industry 4.0, which will stand them in good stead.

Zacks Equity Research

Medtronic Displays All-Business-Line Growth Despite Cost Woes

by Zacks Equity Research

Medtronic's (MDT) Diabetes group is expanding internationally on the strong rollout of its MiniMed 670G in untapped markets.

Trina Mukherjee headshot

Digital Diabetes Management Gains Momentum: 3 Stocks in Focus

by Trina Mukherjee

With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.

Zacks Equity Research

Medtronic Gets FDA Nod for IN.PACT AV for ESRD Patients

by Zacks Equity Research

Medtronic (MDT) receives FDA clearance for IN.PACT AV for the treatment of arteriovenous failures in patients undergoing hemodialysis.